Option Care Health, Inc. to Post FY2024 Earnings of $1.19 Per Share, William Blair Forecasts (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCH) – Equities research analysts at William Blair boosted their FY2024 earnings estimates for Option Care Health in a note issued to investors on Wednesday, April 24th. William Blair analyst M. Larew now anticipates that the company will post earnings of $1.19 per share for the year, up from their prior forecast of $1.17. The consensus estimate for Option Care Health’s current full-year earnings is $1.13 per share. William Blair also issued estimates for Option Care Health’s Q1 2025 earnings at $0.30 EPS, Q2 2025 earnings at $0.35 EPS, Q4 2025 earnings at $0.41 EPS and FY2025 earnings at $1.43 EPS.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.04. The business had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.10 billion. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The company’s revenue was up 12.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.21 EPS.

Several other brokerages also recently weighed in on OPCH. Jefferies Financial Group boosted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, March 4th. Barrington Research restated an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research report on Wednesday.

Option Care Health Stock Down 2.2 %

Shares of NASDAQ:OPCH opened at $29.93 on Thursday. The company has a market capitalization of $5.20 billion, a PE ratio of 19.69, a P/E/G ratio of 1.74 and a beta of 1.22. The company has a current ratio of 1.77, a quick ratio of 1.33 and a debt-to-equity ratio of 0.74. Option Care Health has a twelve month low of $24.23 and a twelve month high of $35.74. The firm has a 50 day simple moving average of $32.13 and a 200-day simple moving average of $31.52.

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the company’s stock in a transaction on Monday, February 26th. The shares were bought at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the purchase, the director now owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Option Care Health

Several institutional investors have recently bought and sold shares of OPCH. Assenagon Asset Management S.A. grew its stake in shares of Option Care Health by 0.9% during the 1st quarter. Assenagon Asset Management S.A. now owns 828,970 shares of the company’s stock worth $27,804,000 after purchasing an additional 7,043 shares during the period. Louisiana State Employees Retirement System grew its stake in shares of Option Care Health by 2.6% during the 1st quarter. Louisiana State Employees Retirement System now owns 51,000 shares of the company’s stock worth $1,711,000 after purchasing an additional 1,300 shares during the period. Norden Group LLC grew its stake in shares of Option Care Health by 1,043.1% during the 1st quarter. Norden Group LLC now owns 121,592 shares of the company’s stock worth $4,078,000 after purchasing an additional 110,955 shares during the period. Lifestyle Asset Management Inc. acquired a new position in shares of Option Care Health during the 1st quarter worth $211,000. Finally, State of Michigan Retirement System grew its stake in shares of Option Care Health by 2.4% during the 1st quarter. State of Michigan Retirement System now owns 43,459 shares of the company’s stock worth $1,458,000 after purchasing an additional 1,000 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.